Results 1 to 10 of about 596,319 (219)

Clinical adoptive regulatory T Cell therapy: State of the art, challenges, and prospective

open access: yesFrontiers in Cell and Developmental Biology, 2023
Rejection of solid organ transplant and graft versus host disease (GvHD) continue to be challenging in post transplantation management. The introduction of calcineurin inhibitors dramatically improved recipients’ short-term prognosis.
Leila Amini   +7 more
doaj   +1 more source

Specific Anti-SARS-CoV-2 Humoral and Cellular Immune Responses After Booster Dose of BNT162b2 Pfizer-BioNTech mRNA-Based Vaccine: Integrated Study of Adaptive Immune System Components

open access: yesFrontiers in Immunology, 2022
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), is modifying human activity all over the world with significant health and economic burden. The advent of the SARS-CoV-2 pandemic prompted the
Rosalia Busà   +16 more
doaj   +1 more source

Defining in vitro topical antimicrobial and antibiofilm activity of epoxy-tigliane structures against oral pathogens

open access: yesJournal of Oral Microbiology, 2023
Background Peri-implantitis has become an inexorable clinical challenge in implantology. Topical immunomodulatory epoxy-tiglianes (EBCs), derived from the Queensland blushwood tree, which induce remodeling and resolve dermal infection via induction of ...
Wenya Xue   +9 more
doaj   +1 more source

Immune Response after the Fourth Dose of SARS-CoV-2 mRNA Vaccine Compared to Natural Infection in Three Doses’ Vaccinated Solid Organ Transplant Recipients

open access: yesViruses, 2022
Solid organ transplant recipients (SOTRs) show higher rates of COVID-19 breakthrough infection than the general population, and nowadays, vaccination is the key preventative strategy.
Rosalia Busà   +10 more
doaj   +1 more source

Mesenchymal stromal cells for the prophylaxis and treatment of graft-versus-host disease—a meta-analysis

open access: yesStem Cell Research & Therapy, 2020
Background Graft-versus-host disease (GvHD) is the main life-threatening complication of allogeneic hematopoietic stem cell transplantation (HSCT). Thirty to 80% of GvHD patients do not respond to first-line treatment and a second-line treatment is not ...
Cynthia Morata-Tarifa   +3 more
doaj   +1 more source

Alginate oligosaccharides enhance diffusion and activity of colistin in a mucin-rich environment

open access: yesScientific Reports, 2022
In a number of chronic respiratory diseases e.g. cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD), the production of viscous mucin reduces pulmonary function and represents an effective barrier to diffusion of inhaled therapies e.g ...
Joana Stokniene   +5 more
doaj   +1 more source

Analysis of the Specific Immune Response after the Third Dose of mRNA COVID-19 Vaccines in Organ Transplant Recipients: Possible Spike-S1 Reactive IgA Signature in Protection from SARS-CoV-2 Infection

open access: yesMicroorganisms, 2022
Background: Several studies have indicated that anti-SARS-CoV-2 mRNA vaccinations are less effective in inducing robust immune responses among solid organ transplant recipients (SOTRs) compared with the immunocompetent. The third dose of vaccine in SOTRs
Monica Miele   +11 more
doaj   +1 more source

Imaging of hepatocellular carcinoma recurrence after liver transplantation

open access: yesInsights into Imaging, 2023
Liver transplantation (LT) provides the highest survival benefit to patients with unresectable hepatocellular carcinoma (HCC). The Milan criteria have been developed for the selection of LT candidates with the goal of improving survival and maintaining ...
Giuseppe Mamone   +12 more
doaj   +1 more source

Generation of induced pluripotent stem cell lines from helper and cytotoxic T cells of healthy individuals

open access: yesStem Cell Research, 2023
T lymphocytes are the most abundant mononuclear blood cells and can serve as a source for generating induced pluripotent stem cells (iPSCs) for disease modeling or drug development.
Timothy Kamaldinov   +3 more
doaj   +1 more source

Advanced therapies [PDF]

open access: yesFarmacia Hospitalaria, 2020
-
María Jesús Lamas-Díaz   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy